Anaconda Biomed
Barcelona, ES · 4 known investors
Anaconda Biomed develops neurovascular medical devices, including the ANA funnel-based aspiration catheter, for endovascular treatment of acute ischemic stroke from large vessel occlusion, such as mechanical thrombectomy. Its self-expanding, single-use catheter provides temporary vascular flow restriction and clot collection for neurointervention procedures.
HardwareHealthtechMedical Devices
Investors · 4
In the news
Frequently asked questions
- What does Anaconda Biomed do?
- Anaconda Biomed develops neurovascular medical devices, including the ANA funnel-based aspiration catheter, for endovascular treatment of acute ischemic stroke from large vessel occlusion, such as mechanical thrombectomy. Its self-expanding, single-use catheter provides temporary vascular flow restriction and clot collection for neurointervention procedures.
- Who are Anaconda Biomed's investors?
- Anaconda Biomed's investors include Ysios Capital, Asabys Partners, European Investment Bank, Innogest Capital.
- Where is Anaconda Biomed headquartered?
- Anaconda Biomed is headquartered in Barcelona, ES.